The Oncology Institute, Inc. (TOI)
USD 0.19
(-2.0%)
USD 0.19
(-2.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 324.23 Million | 252.48 Million | 203 Million | 187.51 Million | 155.4 Million | 113.16 Million |
| Cost of Revenue | 264.66 Million | 200.39 Million | 162.15 Million | 150.63 Million | 125.46 Million | 86.87 Million |
| Gross Profit | 59.57 Million | 52.09 Million | 40.84 Million | 36.87 Million | 29.94 Million | 26.28 Million |
| Operating Expenses | 136.59 Million | 124.1 Million | 86.7 Million | 45.07 Million | 32.58 Million | 21.49 Million |
| Selling, General and Administrative Expenses | 113.85 Million | 119.68 Million | 83.36 Million | 41.89 Million | 29.64 Million | 20.38 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 22.74 Million | 4.41 Million | 3.34 Million | 3.17 Million | 2.94 Million | 1.1 Million |
| Cost and Expenses | 401.25 Million | 324.49 Million | 248.86 Million | 195.71 Million | 158.04 Million | 108.37 Million |
| Operating Income | -77.01 Million | -72 Million | -45.85 Million | -8.19 Million | -2.63 Million | 4.78 Million |
| Interest Expense | 6.77 Million | 4.08 Million | 320 Thousand | 347.06 Thousand | 3375.00 | 1592.00 |
| Income Tax Expense | -36 Thousand | 247 Thousand | -671 Thousand | -492.82 Thousand | 1.38 Million | 912.74 Thousand |
| Earnings before Tax | -83.1 Million | 1.9 Million | -11.59 Million | -14.81 Million | -2.63 Million | 4.86 Million |
| Net Income | -83.06 Million | 1.65 Million | -10.92 Million | -14.32 Million | -4.02 Million | 3.94 Million |
| Earnings Per Share Basic | -0.92 | 0.02 | -0.16 | -0.24 | -0.06 | 0.14 |
| Earnings Per Share Diluted | -0.92 | 0.02 | -0.16 | -0.24 | -0.06 | 0.14 |
| Weighted Average Shares Outstanding | 73.74 Million | 72.79 Million | 66.23 Million | 59.11 Million | 64.44 Million | 28.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 73.74 Million | 80.6 Million | 66.23 Million | 59.11 Million | 64.44 Million | 28.75 Million |
| Gross Margin | 0.18 | 0.21 | 0.20 | 0.20 | 0.19 | 0.23 |
| EBIT Margin | -0.22 | -0.27 | -0.20 | -0.06 | 0.00 | 0.05 |
| Profit Margin | -0.26 | 0.01 | -0.05 | -0.08 | -0.03 | 0.03 |
| EBITDA | -70.45 Million | 8.4 Million | -7.93 Million | -11.29 Million | 307.1 Thousand | 9.07 Million |
| Earnings Before Tax Margin | -0.24 | -0.29 | -0.23 | -0.04 | -0.02 | 0.04 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 98.57 Million | 94.66 Million | 324.23 Million | 85.78 Million | 82.03 Million | 80.22 Million |
| Cost of Revenue | 87.07 Million | 84.18 Million | 270.53 Million | 72.98 Million | 66.05 Million | 65.1 Million |
| Gross Profit | 11.5 Million | 10.48 Million | 53.7 Million | 12.8 Million | 15.97 Million | 15.11 Million |
| Operating Expenses | 27.87 Million | 28.45 Million | 113.73 Million | 28.08 Million | 29.9 Million | 30.05 Million |
| Selling, General and Administrative Expenses | 27.87 Million | 28.45 Million | - | 28.08 Million | 28.2 Million | 28.72 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -117 Thousand | 68 Thousand | -704 Thousand | -350 Thousand | -140 Thousand | -357 Thousand |
| Cost and Expenses | 114.94 Million | 112.63 Million | 384.27 Million | 101.07 Million | 95.96 Million | 95.16 Million |
| Operating Income | -16.36 Million | -17.97 Million | -60.03 Million | -15.28 Million | -13.92 Million | -14.93 Million |
| Interest Expense | 2.11 Million | 1.98 Million | 6.77 Million | -1.24 Million | 2.69 Million | 2.67 Million |
| Income Tax Expense | -2.8 Million | -3.61 Million | -36 Thousand | -87 Thousand | 135 Thousand | 99 Thousand |
| Earnings before Tax | -15.47 Million | -19.88 Million | -83.1 Million | -18.84 Million | -17.28 Million | -16.79 Million |
| Net Income | -12.67 Million | -16.27 Million | -67.87 Million | -15.31 Million | -17.41 Million | -16.89 Million |
| Earnings Per Share Basic | -0.17 | -0.22 | - | -0.21 | -0.24 | -0.23 |
| Earnings Per Share Diluted | -0.17 | -0.22 | - | -0.21 | -0.24 | -0.23 |
| Weighted Average Shares Outstanding | 74.74 Million | 74.23 Million | 73.74 Million | 73.46 Million | 73.46 Million | 74.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.74 Million | 74.23 Million | 73.74 Million | 73.46 Million | 73.46 Million | 74.11 Million |
| Gross Margin | 0.12 | 0.11 | 0.17 | 0.15 | 0.19 | 0.19 |
| EBIT Margin | -0.15 | -0.17 | - | -0.16 | -0.14 | -0.16 |
| Profit Margin | -0.13 | -0.17 | -0.21 | -0.18 | -0.21 | -0.21 |
| EBITDA | -14.84 Million | -16.48 Million | - | -13.7 Million | -11.42 Million | -12.93 Million |
| Earnings Before Tax Margin | -0.17 | -0.19 | -0.19 | -0.18 | -0.17 | -0.19 |
PMV
MTWO
VMUK
SEQI
7363
1905